Clover Health Investments, Corp.

CLOV Healthcare Healthcare Plans

Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024. In the quarter to June 2026, revenue grew 55.6%, EPS grew 350.0% and free cash flow grew 406.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

4.48 0.20 −4.27%
Market cap
$2.5B
P/E
0.0×
Fwd P/E
292×
Dividend yield
—
F-score
3/9
Altman Z
0.44
Beneish M
−1.72
Dividend safety
n/a
Dec '17 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — 4 4 6 6 3
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
— 0.00 2.21 1.04 0.41 0.37 1.13 0.63
Altman Z-Score
— — (2.89) (0.32) (2.31) (2.96) 0.92 0.44
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 46.37 0.00
Altman Z″-Score (non-manufacturers)
— — (14.99) (6.05) (7.83) (11.78) (9.94) (12.26)
P/Operating CF
— (24.24) (24.83) (19.16) (2.16) (1.79) (17.98) (17.65)
Beneish M-Score
— — — — (3.03) (3.42) (3.07) (1.72)
P/B ratio
— 121,753.54 0.00 2.85 1.27 1.62 4.52 3.90
EV/Sales
— 0.00 2.26 0.65 0.13 0.20 0.98 0.57
EV/EBITDA
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/FCF
— 0.00 (12.73) (3.40) (0.67) (1.71) 40.36 (16.01)
Current Ratio
— 0.00 1.16 2.02 1.45 1.64 1.61 1.47
Net Debt/EBITDA
— 0.00 (0.43) 0.96 1.16 1.14 4.72 1.40
Debt/Equity
— 0.00 (0.21) 0.04 0.00 0.00 0.00 0.00
ROE
— 117.88% 44.48% 1,591.19% (75.78%) (66.34%) (13.71%) (26.33%)
ROA
— (725,298.11%) (102.03%) (96.51%) (38.60%) (30.94%) (7.47%) (15.25%)
ROIC
— 0.00% 0.00% 0.00% (756.23%) (255.82%) (23.91%) (28.37%)
Return on Tangible Assets
— 308,251.69% (493.60%) (153.78%) (170.43%) (124.09%) (31.88%) (81.15%)
Average Days of Receivables
— 0.00 27.18 15.45 31.36 18.58 13.72 17.99
Earnings Yield
— 0.00% (9.17%) (38.44%) (75.79%) (46.88%) (2.86%) (7.34%)
Free Cash Flow Yield
— 0.00% (8.01%) (18.43%) (46.06%) (31.38%) 2.16% (5.73%)
Free Cash Flow per Share
— (1.82) (1.34) (0.69) (0.44) (0.30) 0.07 (0.13)
Book value per Share
— 0.00 (6.91) 1.31 0.75 0.59 0.70 0.60
Free Cash Flow
— (159.90) (119.19) (283.05) (208.39) (145.25) 33.29 (68.98)
EV/EBIT
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates